amphetamine has been researched along with neurotensin in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (12.90) | 18.7374 |
| 1990's | 8 (25.81) | 18.2507 |
| 2000's | 14 (45.16) | 29.6817 |
| 2010's | 5 (16.13) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edwardson, JA; Keith, AB; Lloyd, S; Sahgal, A | 1 |
| Meisenberg, G; Simmons, WH | 1 |
| Kalivas, PW | 1 |
| Barbeau, A; De Michele, G; Jolicoeur, FB; St-Pierre, S | 1 |
| Costentin, J; Nouel, D | 1 |
| Brun, P; Fournier, M; Le Fur, G; Mons, G; Rodier, D; Soubrié, P; Souilhac, J; Steinberg, R; Terranova, JP | 1 |
| Koob, GF; Maldonado, R; Robledo, P | 1 |
| Rompré, PP | 1 |
| Feifel, D; Reza, TL; Robeck, SL | 1 |
| Althaus, JS; Feldpausch, DL; Merchant, KM; Needham, LM; Stone, MP; Svensson, KA; Yamamoto, BK | 1 |
| Feldpaush, DL; Meng, ZH; Merchant, KM | 1 |
| Davis, MD; Feifel, D; Reza, TL; Wustrow, DJ | 1 |
| Perron, S; Rompré, P | 1 |
| Accili, D; Betancur, C; Cazillis, M; Fuchs, S; Lépée-Lorgeoux, I; Rostène, W | 1 |
| Arnt, J; Byskov, L; Didriksen, M; Hertel, P | 1 |
| Boules, M; Fauq, A; McCormick, D; Richelson, E; Warrington, L | 1 |
| Bauco, P; Rompré, PP | 1 |
| Boules, M; Fauq, A; McCormick, D; McMahon, B; Richelson, E; Stewart, J; Wang, R; Warrington, L; Yerbury, S | 1 |
| Betancur, C; Giros, B; Hamon, M; Roubert, C; Soubrié, P; Spielewoy, C | 1 |
| Bauco, P; Blackburn, A; Dewar, K; Rompré, PP | 1 |
| Bérod, A; Colussi-Mas, J; Lambás-Señas, L; Panayi, F; Renaud, B; Scarna, H | 1 |
| Deitemeyer, N; Dobner, PR; Egnatashvili, V; Kinkead, B; Murray, T; Nemeroff, CB | 1 |
| Gruber, SH; Mathé, AA; Nomikos, GG | 1 |
| Deutch, AY; Dobner, PR; Fadel, J | 1 |
| Ashton, D; Beckett, SR; Bennett, GW; Langlois, X; Norman, C; Spicer, CH | 1 |
| Feifel, D; Melendez, G; Murray, RJ; Rullan, MA; Shilling, PD; Tina Tran, DN | 1 |
| Boules, M; Briody, S; Fauq, I; Oliveros, A; Richelson, E | 1 |
| Binder, EB; Cáceda, R; Kinkead, B; Nemeroff, CB | 1 |
| Rompré, PP; Rouibi, K | 1 |
| Abulseoud, OA; Ayers-Ringler, J; Choi, DS; Choi, S; Hitschfeld, MJ; Oliveros, A; Vadnie, CA | 1 |
| Bédard, AM; Bouchard, C; Lévesque, D; Minogianis, EA; Rompré, PP; Samaha, AN; Servonnet, A | 1 |
31 other study(ies) available for amphetamine and neurotensin
| Article | Year |
|---|---|
[D-TRP11]-neurotensin, unlike alpha-flupenthixol, may not block amphetamine-induced hyperactivity in rats.
Topics: Amphetamine; Animals; Flupenthixol; Grooming; Male; Motor Activity; Neurotensin; Rats; Rats, Inbred Strains; Thioxanthenes; Time Factors | 1989 |
Motor hypoactivity induced by neurotensin and related peptides in mice.
Topics: Amphetamine; Animals; Drug Interactions; Drug Tolerance; Grooming; Injections, Intraventricular; Male; Mice; Motor Activity; Naloxone; Neurotensin; Oligopeptides; Peptides; Structure-Activity Relationship; Xenopus Proteins | 1985 |
Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. II. Involvement of the mesolimbic dopamine system.
Topics: Amphetamine; Animals; Behavior, Animal; Caffeine; Corpus Striatum; Dopamine; Enkephalin, Methionine; Haloperidol; Injections, Intraventricular; Limbic System; Male; Motor Activity; Neurotensin; Nucleus Accumbens; Rats; Rats, Inbred Strains; Tegmentum Mesencephali | 1985 |
Neurotensin affects hyperactivity but not stereotypy induced by pre and post synaptic dopaminergic stimulation.
Topics: Amphetamine; Animals; Apomorphine; Dopamine; Humans; Hyperkinesis; Male; Neurotensin; Nomifensine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Synaptic Transmission | 1983 |
Locomotor effects of [D-Trp11]neurotensin and dopamine transmission in rats.
Topics: Amphetamine; Animals; Dopamine; Motor Activity; Neurotensin; Nucleus Accumbens; Piperazines; Rats; Rats, Sprague-Dawley; Synaptic Transmission | 1994 |
SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Dopamine; Male; Motor Activity; Neurotensin; Nucleus Accumbens; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Synaptic Transmission; Tegmentum Mesencephali | 1994 |
Neurotensin injected into the nucleus accumbens blocks the psychostimulant effects of cocaine but does not attenuate cocaine self-administration in the rat.
Topics: Amphetamine; Animals; Cocaine; Male; Microinjections; Motor Activity; Neurotensin; Nucleus Accumbens; Rats; Rats, Wistar; Self Administration | 1993 |
Repeated activation of neurotensin receptors sensitizes to the stimulant effect of amphetamine.
Topics: Amphetamine; Animals; Brain; Injections, Intraventricular; Male; Motor Activity; Neurotensin; Rats; Receptors, Neurotensin; Stimulation, Chemical | 1997 |
Pro-dopamine effects of neurotensin on sensorimotor gating deficits.
Topics: Acoustic Stimulation; Amphetamine; Analysis of Variance; Animals; Apomorphine; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Neural Inhibition; Neurotensin; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Reflex, Startle | 1997 |
The role of dopamine D4 receptor in the induction of behavioral sensitization to amphetamine and accompanying biochemical and molecular adaptations.
Topics: Adaptation, Physiological; Amphetamine; Animals; Behavior, Animal; Cerebellum; Dopamine; Genes, fos; Male; Motor Activity; Neurotensin; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D4; RNA, Messenger | 1998 |
Clozapine and haloperidol block the induction of behavioral sensitization to amphetamine and associated genomic responses in rats.
Topics: Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Gene Expression Regulation; Genes, fos; Haloperidol; In Situ Hybridization; Injections, Subcutaneous; Male; Motor Activity; Neurotensin; Nucleus Accumbens; Peptide Fragments; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1998 |
Novel antipsychotic-like effects on prepulse inhibition of startle produced by a neurotensin agonist.
Topics: Adrenergic Agents; Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Dizocilpine Maleate; Dopamine Agonists; Excitatory Amino Acid Antagonists; Hallucinogens; Male; Neurotensin; Rats; Rats, Sprague-Dawley; Reflex, Startle | 1999 |
Evidence for a role of endogenous neurotensin in the initiation of amphetamine sensitization.
Topics: Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; Motor Activity; Neurotensin; Pyrazoles; Quinolines; Rats; Rats, Long-Evans; Receptors, Neurotensin; Time Factors | 2000 |
Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D(3) receptor deficient mice.
Topics: Amphetamine; Animals; Antipsychotic Agents; Brain; Catalepsy; Cocaine; Dopamine Uptake Inhibitors; Female; Gene Expression; Haloperidol; Male; Mice; Mice, Mutant Strains; Motor Activity; Neurotensin; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA, Messenger | 2001 |
Induction of tolerance to the suppressant effect of the neurotensin analogue NT69L on amphetamine-induced hyperactivity.
Topics: Amphetamine; Animals; Body Temperature; Catalepsy; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Tolerance; Male; Motor Activity; Neurotensin; Peptide Fragments; Rats; Rats, Wistar; Time Factors | 2001 |
Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats.
Topics: Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Motor Activity; Neurotensin; Oxidopamine; Parkinson Disease, Secondary; Peptide Fragments; Rats; Rats, Sprague-Dawley | 2001 |
Central neurotensin receptor activation produces differential behavioral responses in Fischer and Lewis rats.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Injections; Male; Microinjections; Motor Activity; Neurotensin; Peptide Fragments; Prefrontal Cortex; Rats; Rats, Inbred F344; Rats, Inbred Lew; Receptors, Neurotensin; Species Specificity; Time Factors; Ventral Tegmental Area | 2003 |
Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier.
Topics: Amphetamine; Animals; Behavior, Animal; Blood Glucose; Blood-Brain Barrier; Body Temperature; Brain; Catalepsy; Cocaine; Drug Tolerance; Haloperidol; Hyperkinesis; Hypothermia; Male; Neurotensin; Peptide Fragments; Rats; Rats, Sprague-Dawley; Time Factors | 2003 |
Altered neurotensin mrna expression in mice lacking the dopamine transporter.
Topics: Amphetamine; Animals; Brain; Dopamine Agents; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Gene Expression; Haloperidol; In Situ Hybridization; Membrane Glycoproteins; Membrane Transport Proteins; Mental Disorders; Mice; Nerve Tissue Proteins; Neurotensin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2004 |
Excitotoxic lesions of the prefrontal cortex attenuate the potentiation of amphetamine-induced locomotion by repeated neurotensin receptor activation.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Ibotenic Acid; Injections, Intraventricular; Locomotion; Male; Neurotensin; Prefrontal Cortex; Rats; Receptors, Neurotensin | 2004 |
Endogenous neurotensin in the ventral tegmental area contributes to amphetamine behavioral sensitization.
Topics: Adamantane; Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Imidazoles; Injections, Subcutaneous; Male; Microinjections; Motor Activity; Neurotensin; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Ventral Tegmental Area | 2005 |
Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine, or quetiapine.
Topics: Amphetamine; Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Clozapine; Dibenzothiazepines; Female; Haloperidol; Male; Mice; Mice, Inbred C57BL; Neurotensin; Olanzapine; Quetiapine Fumarate; Reflex; Reflex, Startle | 2005 |
Effects of acute and subchronic d-amphetamine on ventral striatal concentrations of neurotensin and neuropeptide Y in rats treated with antipsychotic drugs.
Topics: Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Corpus Striatum; Drug Administration Schedule; Drug Interactions; Extracellular Fluid; Haloperidol; Male; Microdialysis; Neuropeptide Y; Neurotensin; Radioimmunoassay; Rats; Rats, Wistar; Risperidone; Time Factors | 2006 |
Amphetamine-elicited striatal Fos expression is attenuated in neurotensin null mutant mice.
Topics: Amphetamine; Analysis of Variance; Animals; Cell Count; Central Nervous System Stimulants; Corpus Striatum; Drug Interactions; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Neurotensin; Oncogene Proteins v-fos; Pyrazoles; Quinolines | 2006 |
Effects of chronic infusion of neurotensin and a neurotensin NT1 selective analogue PD149163 on amphetamine-induced hyperlocomotion.
Topics: Amphetamine; Animals; Blood-Brain Barrier; Central Nervous System Stimulants; Drug Synergism; Injections, Intraventricular; Male; Motor Activity; Neurotensin; Radioimmunoassay; Rats; Receptors, Neurotensin | 2008 |
The reversal of amphetamine-induced locomotor activation by a selective neurotensin-1 receptor agonist does not exhibit tolerance.
Topics: Amphetamine; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Drug Tolerance; Injections, Subcutaneous; Male; Motor Activity; Neurotensin; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin | 2008 |
Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance.
Topics: Acoustic Stimulation; Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Clozapine; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Haloperidol; Neurotensin; Peptide Fragments; Rats; Sensory Gating | 2010 |
The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion.
Topics: Acoustic Stimulation; Adamantane; Amphetamine; Analysis of Variance; Animals; Apomorphine; Behavior, Animal; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Gait Disorders, Neurologic; Gene Expression Regulation; Imidazoles; Male; Neurotensin; Proto-Oncogene Proteins c-fos; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Reflex, Startle; RNA, Messenger | 2012 |
Role of context in neurotensin-induced sensitization to the locomotor stimulant effect of amphetamine.
Topics: Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Locomotion; Male; Neurotensin; Rats; Rats, Long-Evans | 2014 |
Antipsychotic-like effects of a neurotensin receptor type 1 agonist.
Topics: Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Brain; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Glycogen Synthase Kinase 3; Male; Mice; Mice, Inbred C57BL; Neurotensin; Phosphorylation; Prepulse Inhibition; Psychomotor Agitation; Serine; Time Factors | 2016 |
Neurotensin in the nucleus accumbens reverses dopamine supersensitivity evoked by antipsychotic treatment.
Topics: Amphetamine; Animals; Antipsychotic Agents; Caudate Nucleus; Central Nervous System Stimulants; Dopamine; Haloperidol; Male; Movement; Neurotensin; Nucleus Accumbens; Putamen; Rats, Sprague-Dawley; Receptors, Neurotensin; RNA, Messenger | 2017 |